Literature DB >> 19224145

A method for improved verification of entire IMRT plans by film dosimetry.

Vesna Jacob1, Peter Kneschaurek.   

Abstract

BACKGROUND AND
PURPOSE: : In one entire intensity-modulated radiation therapy (IMRT) plan, beams coming from different directions have different penetration depths in the phantom. Therefore, verifying an entire IMRT plan with a calibration curve for a single depth is error-prone. The aim of this study is to improve the quality of the dose verification of entire IMRT plans with film dosimetry.
MATERIAL AND METHODS: : The dose response of the Kodak EDR2 film to 6-MV photon beams was investigated in a solid-water phantom for different field sizes and depths. A method is proposed for evaluating measurements of the optical density with a calibration curve that takes the response at different depths into account. The described method was tested for three entire IMRT plans. For this purpose, calculated and measured dose distributions were compared, where the measured dose distribution was evaluated using a calibration curve for one depth (5 cm) and a calibration curve derived according to the proposed method.
RESULTS: : All measurements suggest that the dose response significantly depends on the depth in the phantom, while dependencies on field size and off-axes distance are smaller. For tested plans, gamma index < 1 (using 3 mm distance and 3% dose as constrains) was reached for 81% and 91% of the points for one plan (prostate), 81% and 86% for the second plan (prostate), and 74% and 85% for the third plan (liver) when using two calibration curves, respectively.
CONCLUSION: : The method described here corrects for the change of the film response due to the variation of the scattered radiation with the penetration depth. This is achieved by a modified calibration curve, which can enhance the accuracy of the verification of entire IMRT plans.

Entities:  

Mesh:

Year:  2009        PMID: 19224145     DOI: 10.1007/s00066-009-1879-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  44 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.

Authors:  Ronald C McGarry; Lech Papiez; Mark Williams; Tia Whitford; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

3.  6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer.

Authors:  Sabine Semrau; Anette Bier; Ulrike Thierbach; Christian Virchow; Peter Ketterer; Gunther Klautke; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2007-01       Impact factor: 3.621

4.  Dose escalation for non-small cell lung cancer using conformal radiation therapy.

Authors:  J M Robertson; R K Ten Haken; M B Hazuka; A T Turrisi; M K Martel; A T Pu; J F Littles; F J Martinez; I R Francis; L E Quint; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

5.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

6.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

7.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

8.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.

Authors:  Robert Timmerman; Lech Papiez; Ronald McGarry; Laura Likes; Colleen DesRosiers; Stephanie Frost; Mark Williams
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

9.  Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.

Authors:  Branislav Jeremic; Johannes Classen; Michael Bamberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.

Authors:  József Lövey; Bíborka Bereczky; Réka Gilly; István Kenessey; Erzsébet Rásó; Erika Simon; Judit Dobos; Agnes Vágó; Miklós Kásler; Balázs Döme; József Tímár; József Tóvári
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

View more
  3 in total

1.  Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++.

Authors:  Dirk Wolff; Florian Stieler; Brigitte Hermann; Katharina Heim; Sven Clausen; Jens Fleckenstein; Martin Polednik; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

2.  Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique.

Authors:  Hilke Vorwerk; Daniela Wagner; Björn Seitz; Hans Christiansen; Hendrik A Wolff; Clemens F Hess
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

3.  Simple proposal for dosimetry with an Elekta iViewGT™ electronic portal imaging device (EPID) using commercial software modules.

Authors:  Janett Liebich; Jörg Licher; Christian Scherf; Eugen Kara; Nadine Koch; Claus Rödel; Ulla Ramm
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.